Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envafolimab Combined with Endostatin and Chemotherapy in Advanced Mucosal Melanoma
NCT06041724Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
01
Overview
A Phase 2 trial of envafolimab in mucosal melanoma (MM), sponsored by Fudan University. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
envafolimab
03
Conditions
mucosal melanoma (MM)
Beyond the preview
Go deeper on NCT06041724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06041724.